It is likely that capacity of CD8+ TTE to maintain immune surveillance over time at the site of malignant disease in MGUS and MM patients is linked to their retention within BM-resident T cell compartment, namely their BM-residency. Here, CD8A is linked to Miyoshi myopathy.